Evidence map›Paper›PMID 26096126›Full record

ArticleBrain research2015

A pivotal role for enhanced brainstem Orexin receptor 1 signaling in the central cannabinoid receptor 1-mediated pressor response in conscious rats.

Badr Mostafa Ibrahim, Abdel A Abdel-Rahman

Open access · greenAbstract read
In one paragraph

Article in Brain research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Restoration of Rostral Ventrolateral Medulla Cystathionine-The Journal of pharmacology and experimental therapeutics · 2018
    Article
  7. Orexin and Central Modulation of Cardiovascular and Respiratory Function.Current topics in behavioral neurosciences · 2017
    Review
  8. Central GPR109A Activation Mediates Glutamate-Dependent Pressor Response in Conscious Rats.The Journal of pharmacology and experimental therapeutics · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Badr Mostafa IbrahimDepartment of Pharmacology & Toxicology, Brody School of Medicine, East Carolina University, 600 Moye Boulevard, Greenville, NC 27858, United States.
Abdel A Abdel-RahmanDepartment of Pharmacology & Toxicology, Brody School of Medicine, East Carolina University, 600 Moye Boulevard, Greenville, NC 27858, United States. Electronic address: ABDELRAHMANA@ecu.edu.
East Carolina University · US

Funding

Sex/estrogen-dependent vulnerability to alcohol-evoked cardiotoxicity: Role of circadian rhythm regulated enzymesR01AA014441 · NIAAA · EAST CAROLINA UNIVERSITY · PI ABDEL-RAHMAN, ABDEL A · 2004 to 2022
$5.2M
Negative Impact of Alcohol on Cardiovascular NeurobiologyR01AA007839 · NIAAA · EAST CAROLINA UNIVERSITY · PI ABDEL-RAHMAN, ABDEL A · 1995 to 2011
$3.7M
NIAAA NIH HHS 2R01AA07839-19NIAAA NIH HHS R01 AA007839NIAAA NIH HHS R01 AA014441
6 · The paper itself

Abstract

Orexin receptor 1 (OX1R) signaling is implicated in cannabinoid receptor 1 (CB1R) modulation of feeding. Further, our studies established the dependence of the central CB1R-mediated pressor response on neuronal nitric oxide synthase (nNOS) and extracellular signal-regulated kinase1/2 (ERK1/2) phosphorylation in the RVLM. Here, we tested the novel hypothesis that brainstem orexin-A/OX1R signaling plays a pivotal role in the central CB1R-mediated pressor response. Our multiple labeling immunofluorescence findings revealed co-localization of CB1R, OX1R and the peptide orexin-A within the C1 area of the rostral ventrolateral medulla (RVLM). Activation of central CB1R following intracisternal (i.c.) WIN55,212-2 (15μg/rat) in conscious rats caused significant increases in BP and orexin-A level in RVLM neuronal tissue. Additional studies established a causal role for orexin-A in the central CB1R-mediated pressor response because (i) selective blockade of central CB1R (AM251, 30μg/rat; i.c.) abrogated WIN55,212-2-evoked increases in RVLM orexin-A level, (ii) the selective OX1R antagonist SB-408124 (10nmol/rat; i.c.) attenuated orexin-A (3nmol/rat; i.c.) or WIN55,212-2 (15μg/rat; i.c.)-evoked pressor response while selective CB1R blockade (AM251) had no effect on orexin-A (3nmol/rat; i.c.)-evoked pressor response, (iii) direct CB1R activation in the RVLM (WIN55,212-2; 0.1μg/rat) increased RVLM orexin-A and BP. Finally, SB-408124 attenuated WIN55,212-2-evoked increases in RVLM nNOS and ERK1/2 phosphorylation and BP. Our findings suggest that orexin-A/OX1R dependent activation of the RVLM nNOS/ERK1/2 cascade is essential neurochemical mechanism for the central CB1R-mediated pressor response in conscious rats.

Indexed as

AnimalsBenzoxazinesBlood PressureCannabinoid Receptor ModulatorsCardiovascular AgentsHeart RateMaleMedulla OblongataMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3MorpholinesNaphthalenesNeuronsNitric Oxide Synthase Type IOrexin Receptor AntagonistsOrexin Receptors(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanoneBenzoxazinesCannabinoid Receptor ModulatorsCardiovascular AgentsCnr1 protein, ratHcrt protein, ratHcrtr1 protein, ratMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3MorpholinesNaphthalenesNitric Oxide Synthase Type INos1 protein, ratOrexin Receptor AntagonistsOrexin ReceptorsOrexinsPhenylurea CompoundsReceptor, Cannabinoid, CB1SB 408124Tyrosine 3-MonooxygenaseBlood pressureCannabinoid receptor 1Orexin receptor 1Rostral ventrolateral medulla

Identifiers

PMID26096126
PMCPMC4562882
OpenAlexW583182915

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.